---
figid: PMC6620681__zh40041928010001
figlink: pmc/articles/PMC6620681/figure/F0001/
number: Fig. 1
caption: Schematic representation of de novo and salvage pathways for NAD+ biosynthesis.
  The figure summarizes the key features of both the de novo pathway, whereby l-tryptophan
  (Trp) is metabolized to NAD+, and the salvage pathway, whereby NAD+ is synthesized
  from the NAD+ precursors nicotinic acid (NA), nicotinamide (Nam) riboside (NR),
  and Nam. The de novo biosynthesis of NAD+ starts from Trp, which is enzymatically
  converted in a series of reactions to quinolinic acid (QA). QA is converted by quinolinate
  phosphoribosyltransferase (QPRT) to NA mononucleotide (NaMN), which is then converted
  to NA adenine dinucleotide (NaAD) by Nam mononucleotide (NMN) adenylyltransferase
  (NMNAT) enzymes. NAD synthase (NADS) generates NAD+ by the amidation of NaAD. In
  the salvage pathway, NMN is synthesized from Nam by the rate-limiting enzyme, Nam
  phosphoribosyltransferase (NAMPT). NMN is also synthesized from NR via phosphorylation
  by NR kinase (NRK). NMN is converted into NAD+ by NMNATs. NA, the other substrate
  of the NAD+ salvage pathway, is converted by NA phosphoribosyltransferase (NAPRT)
  to NaMN, which is then converted into NaAD by NMNATs and lastly into NAD by NADS.
  Multiple enzymes break down NAD+ to produce Nam and ADP-ribosyl moiety, including
  silent information regulator-2-like enzymes (sirtuins) and poly(ADP-ribose) polymerase
  1 and 2 (PARP-1/2). NMN is a substrate of ectoenzyme CD73, with generation of NR.
  3-HAO, 3-hydroxyanthranilate-3,4-dioxygenase; ACMS, α-amino-β-carboxymuconate-ε-semialdehyde;
  ACMSD, ACMS decarboxylase; AMS, aminomuconic semialdehyde; IDO, indoleamine 2,3-deoxygenase;
  KAT, kynurenine aminotransferase; KMO, kynurenine 3-monooxygenase; MNA, 1-methylnicotinamide;
  NNMT, nicotinamide N-methyltransferase; TCA, tricarboxylic acid cycle; TDO, tryptophan-2,3-dioxygenase.
pmcid: PMC6620681
papertitle: Role of endothelial NAD+ deficiency in age-related vascular dysfunction.
reftext: Anna Csiszar, et al. Am J Physiol Heart Circ Physiol. 2019 Jun 1;316(6):H1253-H1266.
pmc_ranked_result_index: '56878'
pathway_score: 0.9524567
filename: zh40041928010001.jpg
figtitle: De novo and salvage pathways for NAD+ biosynthesis
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6620681__zh40041928010001.html
  '@type': Dataset
  description: Schematic representation of de novo and salvage pathways for NAD+ biosynthesis.
    The figure summarizes the key features of both the de novo pathway, whereby l-tryptophan
    (Trp) is metabolized to NAD+, and the salvage pathway, whereby NAD+ is synthesized
    from the NAD+ precursors nicotinic acid (NA), nicotinamide (Nam) riboside (NR),
    and Nam. The de novo biosynthesis of NAD+ starts from Trp, which is enzymatically
    converted in a series of reactions to quinolinic acid (QA). QA is converted by
    quinolinate phosphoribosyltransferase (QPRT) to NA mononucleotide (NaMN), which
    is then converted to NA adenine dinucleotide (NaAD) by Nam mononucleotide (NMN)
    adenylyltransferase (NMNAT) enzymes. NAD synthase (NADS) generates NAD+ by the
    amidation of NaAD. In the salvage pathway, NMN is synthesized from Nam by the
    rate-limiting enzyme, Nam phosphoribosyltransferase (NAMPT). NMN is also synthesized
    from NR via phosphorylation by NR kinase (NRK). NMN is converted into NAD+ by
    NMNATs. NA, the other substrate of the NAD+ salvage pathway, is converted by NA
    phosphoribosyltransferase (NAPRT) to NaMN, which is then converted into NaAD by
    NMNATs and lastly into NAD by NADS. Multiple enzymes break down NAD+ to produce
    Nam and ADP-ribosyl moiety, including silent information regulator-2-like enzymes
    (sirtuins) and poly(ADP-ribose) polymerase 1 and 2 (PARP-1/2). NMN is a substrate
    of ectoenzyme CD73, with generation of NR. 3-HAO, 3-hydroxyanthranilate-3,4-dioxygenase;
    ACMS, α-amino-β-carboxymuconate-ε-semialdehyde; ACMSD, ACMS decarboxylase; AMS,
    aminomuconic semialdehyde; IDO, indoleamine 2,3-deoxygenase; KAT, kynurenine aminotransferase;
    KMO, kynurenine 3-monooxygenase; MNA, 1-methylnicotinamide; NNMT, nicotinamide
    N-methyltransferase; TCA, tricarboxylic acid cycle; TDO, tryptophan-2,3-dioxygenase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TDO2
  - TSTD1
  - IDO1
  - NNMT
  - ACMSD
  - NAMPT
  - QPRT
  - NAPRT
  - NT5E
  - NOVO
  - Tryptophan
  - Kynurenine
  - Kynurenic acid
  - 3-Hydroxyl kynurenine
  - 3-OHKyn
  - 3-Hydroxyanthranilic acid
  - 3-HAA
  - 3-NAO
  - TCA
  - Quinolinic acid
  - NAMPT
  - Nicotinic acid
  - mononucleotide
  - NAMN
  - NAAD
  - NAD
  - NADS
genes:
- word: TDO
  symbol: TDO
  source: hgnc_alias_symbol
  hgnc_symbol: TDO2
  entrez: '6999'
- word: KAT
  symbol: KAT
  source: hgnc_alias_symbol
  hgnc_symbol: TSTD1
  entrez: '100131187'
- word: IDO
  symbol: IDO
  source: hgnc_prev_symbol
  hgnc_symbol: IDO1
  entrez: '3620'
- word: NNMT
  symbol: NNMT
  source: hgnc_symbol
  hgnc_symbol: NNMT
  entrez: '4837'
- word: ACMSD
  symbol: ACMSD
  source: hgnc_symbol
  hgnc_symbol: ACMSD
  entrez: '130013'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: QPRT
  symbol: QPRT
  source: hgnc_symbol
  hgnc_symbol: QPRT
  entrez: '23475'
- word: NAPRT
  symbol: NAPRT
  source: hgnc_symbol
  hgnc_symbol: NAPRT
  entrez: '93100'
- word: CD73
  symbol: CD73
  source: hgnc_alias_symbol
  hgnc_symbol: NT5E
  entrez: '4907'
chemicals:
- word: NOVO
  source: ''
  identifier: ''
- word: Tryptophan
  source: ''
  identifier: ''
- word: Kynurenine
  source: MESH
  identifier: C029366
- word: Kynurenic acid
  source: MESH
  identifier: D007736
- word: 3-Hydroxyl kynurenine
  source: MESH
  identifier: D017665
- word: 3-OHKyn
  source: MESH
  identifier: C039620
- word: 3-Hydroxyanthranilic acid
  source: MESH
  identifier: D015095
- word: 3-HAA
  source: MESH
  identifier: C048926
- word: 3-NAO
  source: MESH
  identifier: C041691
- word: TCA
  source: MESH
  identifier: C000589078
- word: Quinolinic acid
  source: MESH
  identifier: D017378
- word: NAMPT
  source: MESH
  identifier: C085455
- word: Nicotinic acid
  source: MESH
  identifier: D009539
- word: mononucleotide
  source: MESH
  identifier: D009537
- word: NAMN
  source: ''
  identifier: ''
- word: NAAD
  source: MESH
  identifier: C053851
- word: NAD
  source: MESH
  identifier: D009243
- word: NADS
  source: MESH
  identifier: C055737
diseases: []
---
